ID

Isabelle De Cremoux

de la commission Capital Investissement at AFG

Paris, Île-de-France

Overview 

Isabelle de Cremoux is the CEO of Seventure Partners in Paris, with a background in venture capital, private equity, and corporate development. She has successfully led Seventure Partners' lifesciences department and played key roles in various companies like Exo, MaaT Pharma, and Karius through strategic investments and board memberships. Notable highlights of her career include serving as the President of the Capital Investment Commission at AFG - Association Française de la Gestion financière and being a qualified personality for the French government's "Conseil de l'innovation," showcasing her expertise in the financial and innovation sectors.

Work Experience 

SP

Seventure Partners

  • président du directoire / CEO

    2014 - Current

    In addition to the responsibility of heading the lifesciences team, and to the independent board member position at Comigel, Isabelle has been promoted as président du directoire / CEO in January 2014

  • lifesciences department director

    2001

  • CEO / Directeur General

    2011 - 2014

    In addition to the responsibility of lifesciences, and to the independent board member position at Comigel, Isabelle has been promoted as CEO in October 2011

A-

AFG - Association Française de la Gestion financière

  • Président de la commission Capital Investissement

    2019

    As the president of the Capital Investment Commission for the French Asset Management Association (AFG), I am liaising with the French government and the French Financial Markets Authority (AMF) to improve the capital investment sector in France

G

Gouvernement.fr

  • Qualified personality for the French government "Conseil de l'innovation"

    2018 - 2021

N

Naturex

  • Board Member

    2015 - 2018

COMIGEL sas

  • Independent board member

    2011 - 2018

    as independent board member, the mission is to open my international network, share my experience of innovative fast growing companies, and bring strategic input, especially on nutrition and health fields

Laboratoires Fournier

  • Associate Director of Business Devlopment Departement

    1998 - 2001

PF

PFIZER France

  • Business Devpt Manager

    1993 - 1998

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Raised $32,000,000,000.00 from Starboard Value.

pfizer.com

arthur andersen / EY

  • Auditor

    1991 - 1993

    financial auditor

Education 

Investments 

Exo

Seed

Total funding: $310M

MaaT Pharma

Post Ipo Equity

Total funding: $20M

Karius

Series C

Total funding: $330M

Inalve

Series Unknown

Total funding: $2M

Articles About Isabelle

Relevant Websites